Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Critical Path Institute Seeks "Respected, Well Networked" CEO As Woosley Plans Retirement

This article was originally published in The Pink Sheet Daily

Executive Summary

Board member Bob Assenzo will lead a search committee to find a replacement for CPI's founding force, Raymond Woosley, who will step down next January.

You may also be interested in...



People In The News: Changes At EnVivo, CSL, Biomed, Orexo, NCPA, And More

Deborah Dunsire takes top leadership post at EnVivo and Paul Perreault at CSL Limited; Robert DeLuca to lead U.S. rollout of Orexo’s Zubsolv; Former CMS Deputy Director joins Avalere; more personnel announcements in this month’s column.

Critical Path Institute’s New Business Model: An Interview With CEO Compton

After six months on the job, Carolyn Compton, the institute’s new chief executive, has overhauled the funding rules to allow fees from big pharma to cover overhead as government funding dries up. Successor to founder Raymond Woosley, who retired last year, Compton shares her vision for securing the institute’s finances for the future amid tough economic times.

People In The News: Tracking The Latest Industry Personnel Moves

Presidents & CEOs

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel